PGIM ETF Trust - PGIM Jennison International Opportunities ETF (PJIO) Stock Price

62.808 ▲ +0.8646 (+1.40%)
Open: 62.365 Vol: 800 Day's range: 62.365 - 62.808 Nov 10, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PJIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 63.17▼ 63.17▼ 63.17▼ 62.49▲ 63.27▼
MA10 63.77▼ 63.77▼ 63.77▼ 63.41▼ 63.32▼
MA20 63.41▼ 63.41▼ 63.42▼ 63.71▼ 62.21▲
MA50 62.16▲ 62.01▲ 61.43▲ 63.57▼ 58.28▲
MA100 N/A     N/A     N/A     62.34▲ N/A    
MA200 N/A     N/A     N/A     58.99▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.294▼ -0.324▼ -0.355▼ -0.260▼ -0.208▼
RSI 46.489▼ 47.261▼ 48.140▼ 44.283▼ 55.846▲
STOCH 23.151     23.151     23.151     13.627▼ 39.782    
WILL %R -91.139▼ -91.139▼ -91.139▼ -62.485     -53.305    
CCI -134.594▼ -134.594▼ -134.594▼ -81.459     -15.080    
Latest Filters Detected On PJIO
CDL $PJIO Marubozu Candlestick Pattern Detected Set Alert
PGIM ETF Trust - PGIM Jennison International Opportunities ETF News
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762
Friday, November 07, 2025 07:45 AM
Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)King of Prussia, Pennsylvania--(Newsfile Corp. - November 7, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: ...
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
Friday, November 07, 2025 04:54 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio ...
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
Thursday, November 06, 2025 11:58 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary ...
PJIO historical stock data
date open high low close volume
10/11/25 62.365 62.808 62.365 62.808 800
07/11/25 61.76 61.9434 61.54 61.9434 3,622
06/11/25 62.79 62.79 62.04 62.0894 3,311
05/11/25 62.69 62.958 62.69 62.895 47,712
04/11/25 63.44 63.44 62.7091 62.7091 1,844
03/11/25 64.0094 64.0094 64.0094 64.0094 122
31/10/25 63.8475 63.8475 63.8475 63.8475 192
30/10/25 64.2845 64.2845 64.0942 64.0942 182
29/10/25 64.8682 64.8682 64.8345 64.8349 2,824
28/10/25 64.875 64.92 64.87 64.8785 1,383
Quote Details
52wk Low:43.11
52wk High:66.59
Vol:800
Avg Vol(3m):33.1K
1Y Chng:+10.82%
1M Chng:-2.39%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00